Literature DB >> 25341676

Systematic review of recent dementia practice guidelines.

Jennifer Ngo1, Jayna M Holroyd-Leduc1.   

Abstract

BACKGROUND: dementia is a highly prevalent acquired cognitive disorder that interferes with activities of daily living, relationships and quality of life. Recognition and effective management strategies are necessary to provide comprehensive care for these patients and their families. High-quality clinical practice guidelines can improve the quality and consistency of care in all aspects of dementia diagnosis and management by clarifying interventions supported by sound evidence and by alerting clinicians to interventions without proven benefit.
OBJECTIVE: we aimed to offer a synthesis of existing practice recommendations for the diagnosis and management of dementia, based upon moderate-to-high quality dementia guidelines.
METHODS: we performed a systematic search in EMBASE and MEDLINE as well as the grey literature for guidelines produced between 2008 and 2013.
RESULTS: thirty-nine retrieved practice guidelines were included for quality appraisal by the Appraisal of Guidelines Research and Evaluation II (AGREE-II) tool, performed by two independent reviewers. From the 12 moderate-to-high quality guidelines included, specific practice recommendations for the diagnosis and/or management of any aspect of dementia were extracted for comparison based upon the level of evidence and strength of recommendation.
CONCLUSION: there was a general agreement between guidelines for many practice recommendations. However, direct comparisons between guidelines were challenging due to variations in grading schemes.
© The Author 2014. Published by Oxford University Press on behalf of the British Geriatrics Society. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  clinical practice guideline; dementia; diagnosis; management; older people

Mesh:

Year:  2014        PMID: 25341676     DOI: 10.1093/ageing/afu143

Source DB:  PubMed          Journal:  Age Ageing        ISSN: 0002-0729            Impact factor:   10.668


  41 in total

1.  Associations between informal care, disease, and risk factors: A Spanish country-wide population-based study.

Authors:  Luís González-de Paz; Jordi Real; Alicia Borrás-Santos; José M Martínez-Sánchez; Virginia Rodrigo-Baños; María Dolores Navarro-Rubio
Journal:  J Public Health Policy       Date:  2016-02-11       Impact factor: 2.222

2.  Ginkgo biloba Extract (EGb761), Cholinesterase Inhibitors, and Memantine for the Treatment of Mild-to-Moderate Alzheimer's Disease: A Network Meta-Analysis.

Authors:  Onnita Thancharoen; Chulaporn Limwattananon; Onanong Waleekhachonloet; Thananan Rattanachotphanit; Phumtham Limwattananon; Panita Limpawattana
Journal:  Drugs Aging       Date:  2019-05       Impact factor: 3.923

3.  Planning Ahead for Dementia Research Participation: Insights from a Survey of Older Australians and Implications for Ethics, Law and Practice.

Authors:  Nola Ries; Elise Mansfield; Rob Sanson-Fisher
Journal:  J Bioeth Inq       Date:  2019-07-11       Impact factor: 1.352

4.  Pharmacotherapy for Dementia: A Practical Approach to the Use of Cholinesterase Inhibitors and Memantine.

Authors:  Chit Wai Wong
Journal:  Drugs Aging       Date:  2016-07       Impact factor: 3.923

5.  [Polarity of the freely formulated MMST sentence and state of health of people with dementia : Results of a cross-sectional study].

Authors:  Stefan Sniatecki; Gabriele Meyer; Anna Renom-Guiteras; Martin N Dichter; Herbert Mayer; Astrid Stephan
Journal:  Z Gerontol Geriatr       Date:  2016-05-12       Impact factor: 1.281

6.  A Systematic Review of Practice Guidelines and Recommendations for Discontinuation of Cholinesterase Inhibitors in Dementia.

Authors:  Brenna N Renn; Ali Abbas Asghar-Ali; Stephen Thielke; Angela Catic; Sharyl R Martini; Brian G Mitchell; Mark E Kunik
Journal:  Am J Geriatr Psychiatry       Date:  2017-10-10       Impact factor: 4.105

7.  The effectiveness and unique contribution of neuropsychological tests and the δ latent phenotype in the differential diagnosis of dementia in the uniform data set.

Authors:  Samantha E John; Ashita S Gurnani; Cara Bussell; Jessica L Saurman; Jason W Griffin; Brandon E Gavett
Journal:  Neuropsychology       Date:  2016-11       Impact factor: 3.295

8.  Sex Differences in the Prevalent Use of Oral Formulations of Cholinesterase Inhibitors in Older Adults with Dementia.

Authors:  Lynn Zhu; Paula A Rochon; Andrea Gruneir; Wei Wu; Vasily Giannakeas; Peter C Austin; Nathan M Stall; Lisa McCarthy; Amanda Alberga; Nathan Herrmann; Sudeep S Gill; Susan E Bronskill
Journal:  Drugs Aging       Date:  2019-09       Impact factor: 3.923

9.  The role of the neuropsychologist in memory clinics.

Authors:  Emilia Salvadori; Leonardo Pantoni
Journal:  Neurol Sci       Date:  2020-01-16       Impact factor: 3.307

10.  Predictors of dementia misclassification when using brief cognitive assessments.

Authors:  Janice M Ranson; Elżbieta Kuźma; William Hamilton; Graciela Muniz-Terrera; Kenneth M Langa; David J Llewellyn
Journal:  Neurol Clin Pract       Date:  2019-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.